June 05, 2020 Smoking cessation, weight gain, and cardiovascular risk. Lancet Diabetes Endocrinol. 2020;8:93-95
June 05, 2020 Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8:115-124
Wang T, Lu J, Shi L, Chen G, Xu M, Xu Y, Su Q, Mu Y, Chen L, Hu R, Tang X, Yu X, Li M, Zhao Z, Chen Y, Yan L, Qin G, Wan Q, Dai M, Zhang D, Gao Z et al.
June 04, 2020 Tackling obesity in 2020-with a great resolution comes shared responsibility. Lancet Diabetes Endocrinol. 2020;8:89
The Lancet Diabetes Endocrinology
June 04, 2020 Insulin resistance versus β-cell dysfunction in type 2 diabetes: where public and personalised health meet. Lancet Diabetes Endocrinol. 2020;8:92-93
Chow EYK, Chan JCN
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
Expert Opinions What do you think is the most dangerous risk factor: being sedentary or having a low cardiorespiratory fitness and why?
Steven N. Blair, P.E.D., FACSM, Professor (retired), Departments of Exercise Science and Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA
Expert Opinions Could you discuss on the beneficial impact of lifestyle habits in the prevention and management of cardiovascular disease?
Peter Libby, MD, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA, USA
Expert Opinions Do you think that, beyond drug therapy, lifestyle changes are important in the management of certain types of cancer?
Vincent Fradet, MD, PhD, Associate Professor, Faculty of Medicine; Research Scientist, Cancer Research Centre, CHU de Québec, Université Laval, Québec, QC, Canada
In the Spotlight
Expert Opinions Should we talk about the deleterious impacts of the consumption of energy drinks in public health messages?
By Benoit Arsenault, PhD, Professor, Faculty of Medicine, Université Laval, Centre de recherche de l'IUCPQ, Québec, QC, Canada
Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium
The International Chair on Cardiometabolic Risk